RESI Conference, Boston, Sep 2018, 36 pages Deal and Product Valuations Deal and Product Valuations
Category: Presentations
RESI Conference June 2018 – Deal and Product Valuations
How to value a Biotech Start-up company
Biotech Investment Showcase, London, May 2018, 22 pages How to value a Biotech Start-up company
RESI Conference April 2018 – Deal and Product Valuations
Industry Insight: Valuations
RESI Conference January 2018 – Deal and Product Valuations
RESI Conference November 2017- Deal and Product Valuations
BIO IP & Diagnostics Symposium (IPDx) Keynote Session
Dr. Patrik Frei was the keynote speaker at BIO IP & Diagnostics Symposium (IPDx) on 29th of September 2017. During the session, the Venture Valuation CEO discussed the valuation of biotechnology companies and products and its link to IP. He gave a short introduction to risk-adjusted net present value calculations, the main value drivers and … Continue reading BIO IP & Diagnostics Symposium (IPDx) Keynote Session
Valuation Workshop at RESI Conference – Boston, September 2017
During the last RESI (Redefining Early Stage Investments) Conference – the event series organized by Life Science Nation, a Venture Valuation long-time partner – Dr. Patrik Fried delivered a session on life science deal and product valuations. The notes from the workshop are available to download here
Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017
Venture Valuation CEO, Dr. Patrik Frei is one of the experts working as mentors for MassChallengeCH, a famous startup accelerator. He helps new entrepreneurs understand the concepts and meaning of company valuation. Below, you can find a link to the notes from his workshop about assessing a company prior to valuation. Assessing the Valuation of New … Continue reading Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017